# Tenaya Therapeutics, Inc.: Form 8-K, filed Mar 10, 2025

- Company: [Tenaya Therapeutics, Inc.](/companies/tnya.md) (CIK 1858848)
- Form: 8-K
- Filed: 2025-03-10
- Accepted by EDGAR: Mar 10, 2025, 20:13 ET
- Period: 2025-03-10
- Accession: 0000950170-25-036296
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1858848/000095017025036296/tnya-20250310.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1858848/000095017025036296/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1858848/000095017025036296/tnya-20250310.htm

Filed Mar 10, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-036296. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.